• Open Daily: 10am - 10pm
    Alley-side Pickup: 10am - 7pm

    3038 Hennepin Ave Minneapolis, MN
    612-822-4611

Open Daily: 10am - 10pm | Alley-side Pickup: 10am - 7pm
3038 Hennepin Ave Minneapolis, MN
612-822-4611
Immunogenicity of Biopharmaceuticals

Immunogenicity of Biopharmaceuticals

Hardcover

Series: Biotechnology: Pharmaceutical Aspects, Book 8

Medical Reference

ISBN10: 0387758402
ISBN13: 9780387758404
Publisher: Springer Nature
Published: Mar 21 2008
Pages: 266
Weight: 1.64
Height: 0.84 Width: 7.05 Depth: 10.33
Language: English

A particular issue for biopharmaceuticals that has not been addressed comprehensively in any book, is the potential of an immune response to the biopharmaceutical product. That is, the human body marks the drug as a foreign body, and develops antibodies against the drug. These antibodies may be relatively harmless, but may also cross-react with the endogenous compound, causing autoimmunogenicity. Recent adverse experiences in Europe with Janssen-Ortho's blockbuster product Eprex has increased the attention towards potential immunogenicity of biopharmaceuticals, above all from the regulatory agencies.

Also in

Medical Reference